Literature DB >> 21402518

Can a pharmacist reduce annual costs for Medicare Part D enrollees?

Greg Alston1, Conor Hanrahan.   

Abstract

OBJECTIVE: To determine the ability of a community pharmacist to reduce the annual drug expenditures for Medicare Part D enrollees.
SETTING: Independent community pharmacy. PRACTICE DESCRIPTION: Located in rural North Carolina, one pharmacist and two technicians, 900 prescriptions per week, open 56 hours per week; and median income of $14,500 in 2009. PRACTICE INNOVATION: Drug regimen reviews for 50 Medicare Part D enrollees were performed using the Medicare.gov Web site to determine the potential annual savings available to patients by selecting the lowest-cost prescription drug plan and requesting therapeutic alternatives to expensive medications. The impact of this intervention on the patient's entry into the coverage gap was also explored. MAIN OUTCOME MEASUREMENTS: Annual prescription drug plan cost (in dollars/year), number of patients in coverage gap, number of months to reach coverage gap (MTG) in the Medicare Part D drug program.
RESULTS: 48/50 patients had not selected the lowest-cost prescription plan and had a potential to save $456 per year, 27/50 patients had an opportunity for therapeutic substitution with a potential savings of $1,303 per year, 25 enrollees would reach the coverage gap without an intervention, 16 could be kept out of the gap with an average improvement of 3.02 months' coverage.
CONCLUSION: Pharmacists can use the Medicare.gov Web site to assist Medicare Part D plan enrollees in reducing their out-of-pocket annual expenditures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402518     DOI: 10.4140/TCP.n.2011.182

Source DB:  PubMed          Journal:  Consult Pharm        ISSN: 0888-5109


  2 in total

1.  Medicare part D research and policy highlights, 2012: impact and insights.

Authors:  Denys T Lau; JoAnn Stubbings
Journal:  Clin Ther       Date:  2012-03-13       Impact factor: 3.393

2.  Potential Savings in Medicare Part D for Common Urological Conditions.

Authors:  Peter S Kirk; Tudor Borza; James M Dupree; John T Wei; Chad Ellimoottil; Megan E V Caram; Mary Burkhardt; Joel J Heidelbaugh; Brent K Hollenbeck; Ted A Skolarus
Journal:  Urol Pract       Date:  2018-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.